These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18584335)

  • 1. Inhibitors of GSK-3 prevent corticosterone from inducing COX-1 expression in cardiomyocytes.
    Sun H; Chen QM
    Cardiovasc Toxicol; 2008; 8(2):93-100. PubMed ID: 18584335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P38 MAPK mediates COX-2 gene expression by corticosterone in cardiomyocytes.
    Sun H; Xu B; Inoue H; Chen QM
    Cell Signal; 2008 Nov; 20(11):1952-9. PubMed ID: 18657608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activity of glycogen synthase kinase-3beta: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells.
    Nemoto T; Yokoo H; Satoh S; Yanagita T; Sugano T; Yoshikawa N; Maruta T; Kobayashi H; Wada A
    Brain Res; 2006 Sep; 1110(1):1-12. PubMed ID: 16870161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids induce cyclooxygenase 1 expression in cardiomyocytes: role of glucocorticoid receptor and Sp3 transcription factor.
    Sun H; Sheveleva E; Chen QM
    Mol Endocrinol; 2008 Sep; 22(9):2076-84. PubMed ID: 18599619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lithium treatment up-regulates cell surface Na(V)1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: enhancement of Na(+) influx, Ca(2+) influx and catecholamine secretion after lithium withdrawal.
    Yanagita T; Maruta T; Nemoto T; Uezono Y; Matsuo K; Satoh S; Yoshikawa N; Kanai T; Kobayashi H; Wada A
    Neuropharmacology; 2009 Sep; 57(3):311-21. PubMed ID: 19486905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes.
    Tseng AS; Engel FB; Keating MT
    Chem Biol; 2006 Sep; 13(9):957-63. PubMed ID: 16984885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.
    Seyed M; Dimario JX
    J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of rat cortical neurons from prostaglandin E2-induced apoptosis by glycogen synthase kinase-3 inhibitors.
    Takadera T; Ohyashiki T
    Neurosci Lett; 2006 May; 400(1-2):105-9. PubMed ID: 16504398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
    Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
    Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glycogen synthase kinase-3 enhances the expression of alkaline phosphatase and insulin-like growth factor-1 in human primary dermal papilla cell culture and maintains mouse hair bulbs in organ culture.
    Yamauchi K; Kurosaka A
    Arch Dermatol Res; 2009 Jun; 301(5):357-65. PubMed ID: 19238412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 regulation of chromatin segregation and cytokinesis in mouse preimplantation embryos.
    Acevedo N; Wang X; Dunn RL; Smith GD
    Mol Reprod Dev; 2007 Feb; 74(2):178-88. PubMed ID: 16941690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells.
    Noma T; Takahashi-Yanaga F; Arioka M; Mori Y; Sasaguri T
    Biochem Pharmacol; 2016 Sep; 116():120-9. PubMed ID: 27453433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.
    Beurel E; Blivet-Van Eggelpoël MJ; Kornprobst M; Moritz S; Delelo R; Paye F; Housset C; Desbois-Mouthon C
    Biochem Pharmacol; 2009 Jan; 77(1):54-65. PubMed ID: 18938143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
    Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
    Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
    Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
    Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism.
    Sun H; Xu B; Sheveleva E; Chen QM
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):25-32. PubMed ID: 18657281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
    Lamarre M; Desrosiers RR
    Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes.
    Evenson AR; Fareed MU; Menconi MJ; Mitchell JC; Hasselgren PO
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2226-38. PubMed ID: 16051512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.